Aidsmap
For patients with HIV viral load is key in immune response to yellow fever vaccine
Viral load is the only factor associated
with a poorer antibody response to the yellow fever vaccine in patients with
HIV, according to a French study published in the online edition of the Journal of Acquired Immune Deficiency
Syndromes.
For patients vaccinated after diagnosis
with HIV, an undetectable viral load was the “unique determinant” of
Categories: frontpage
Contraception in HIV prevention trials: injectable hormonal methods more effective?
Women
using injectable (hormonal) contraceptives had a significantly lower rate of
pregnancy compared to those using oral contraception in a major HIV prevention study, researchers report in the advance online edition of AIDS.
However, the same study also found that women who used an injectable hormonal contraceptive method were at higher risk of
Categories: frontpage
Men who have sex with men may now be the highest-risk group for HIV in Africa, IAVI study suggests
Men who have sex with men may now be at considerably higher
risk of acquiring HIV than other at-risk groups such as female sex workers or
young people of either sex, if findings by the International AIDS Vaccine
Initiative (IAVI) of HIV incidence at two centres in Kenya can be generalised to other
populations.
The
Categories: frontpage
HIV care providers in US struggling to cope with rising patient numbers
HIV doctors in the US are struggling to
meet the demands of a rising patient caseload, according to the findings of a
national survey.
Two-thirds of HIV treatment providers
reported an increase in patient numbers, and a third reported difficulties
being reimbursed for the care they provided.
The second annual HealthHIV State of Primary
Categories: frontpage
Quarter of men resume sex before wounds from circumcision fully healed in Zambian study
Approximately a quarter of men undergoing circumcision
resume sexual activity before their wounds have fully healed, Zambian research
published in the online edition of AIDS
shows.
Most of the men reporting the early resumption of sexual
activity engaged in unprotected sex, often with multiple partners.
The investigators calculated that early resumption of sexual
activity at this
Categories: frontpage
Raltegravir/Truvada HIV PEP regimen well tolerated with no infections after its use
Raltegravir could have a “useful” role in HIV post-exposure
prophylaxis, according to investigators from the US writing in the online
edition of the Journal of Acquired Immune
Deficiency Syndromes.
Doctors in Boston, Massachusetts, prescribed a post-exposure
prophylaxis (PEP) regimen of raltegravir (Isentress)
with tenofovir and FTC (Truvada) to
100 patients after possible sexual exposure to HIV.
Categories: frontpage
For study participants, PrEP was an opportunity to save their relationship
Seeking to understand why adherence to pre-exposure
prophylaxis (PrEP) was extremely high in a study of serodiscordant couples,
qualitative researchers have found that trial participants saw PrEP as a way
they could preserve their relationship despite the pressures created by the
knowledge of different HIV status and the risk of infection. In an article
published
Categories: frontpage
Majority of HIV-positive patients in US not receiving regular medical care
Only 45% of
HIV-positive patients in the US are receiving regular medical monitoring,
research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes suggests.
The study also showed
that a third of patients were not being linked with specialist HIV care within
the first year of their diagnosis with the
Categories: frontpage
Hormonal contraception and HIV risk: no increased risk in South African cohort
During a study of 5567 South African women, looking at the effect of hormonal contraception on HIV acquisition, 270 women became HIV-infected. The researchers report that use
of hormonal contraception did not increase the risk, overall, of becoming HIV positive,
compared to non-hormonal contraception, in the advance online
edition of AIDS.
There
Categories: frontpage
Hormonal contraception and HIV risk: no increased risk in South African cohort
Of
the 270 South African women from a cohort of 5567 who became HIV-infected, use
of hormonal contraception did not increase their risk, overall, of getting HIV
compared to non-hormonal contraception, researchers report in the advance online
edition of AIDS.
There was a modest but non-significant trend towards an increased risk of getting
Categories: frontpage
Rapid HIV test performance poorer with oral fluid than blood, especially when prevalence is low
The
performance of OraQuick, a widely used rapid point-of-care test for HIV
diagnosis, is slightly poorer when testing oral fluid samples than when testing
blood samples, according to a meta-analysis published in the online edition of
Lancet Infectious Diseases this week.The authors also found that if the test
is used in low-prevalence settings with oral
Categories: frontpage
Rapid HIV test performance poorer with oral fluid than blood, especially when prevalence is low
The
performance of OraQuick, a widely used rapid point-of-care test for HIV
diagnosis, is slightly poorer when testing oral fluid samples than when testing
blood samples, according to a meta-analysis, published in the online edition of
Lancet Infectious Diseases this week.The authors also found that if the test
is used in low prevalence settings with
Categories: frontpage
Vitamin D supplements benefit bone metabolism of younger patients taking tenofovir
Vitamin D supplementation is associated with an improvement
in a key marker of bone health in HIV-positive young adults treated with
tenofovir, US research published in Clinical
Infectious Diseases shows.
Treatment with vitamin D3 lead to a significant fall in
parathyroid hormone levels, an important regulator of calcium which has a
significant role in bone metabolism.
Categories: frontpage
Smoking cessation counselling and treatment during routine HIV care helps patients to quit
The provision of
smoking cessation counselling and therapy during routine HIV care increases the
chances that patients will quit smoking and stay stopped, according to Swiss
research published in HIV Medicine.
Physicians at the
Zurich HIV clinic received training about smoking cessation counselling and the
use of medication to help those wanting to quit.
Compared to
Categories: frontpage
English public health indicators to include late HIV diagnosis
The Department of Health this week announced the 66
‘indicators’ with which the performance of the new public health system will be
measured. To the relief of HIV campaigners, these include a measure of late HIV
diagnosis.
From 2013, management of the public health system in England
will move from NHS primary care trusts to
Categories: frontpage
English public health indicators to include late HIV diagnosis
The Department of Health this week announced the 66
‘indicators’ with which the performance of the new public health system will be
measured. To the relief of HIV campaigners, these include a measure of late HIV
diagnosis.
From 2013, management of the public health system in England
will move from NHS primary care trusts to
Categories: frontpage
Studies from US and Spain show that hepatitis vaccination programmes not reaching target populations
The majority of US adults at risk of hepatitis B remain
unvaccinated against this potentially life-threatening infection, according to
research published in advance of print in the online edition of Infection.
The research highlighted missed opportunities for
vaccination, especially for individuals who had received health care while in
prison. The authors express concern that vaccination
Categories: frontpage
Can speeding up nevirapine clearance reduce the risk of resistance after PMTCT use?
In
a bid to reduce the risk of nevirapine resistance after the use of single-dose
nevirapine to prevent mother-to-child HIV transmission, several research groups
are now experimenting with the use of drugs that can speed up the clearance of
nevirapine from the mother’s bloodstream after giving birth.
For
example, adding single dose-carbamazepine, a cheap, readily available
anti-convulsant
Categories: frontpage
Can speeding up nevirapine clearance reduce the risk of resistance after PMTCT use?
In
a bid to reduce the risk of nevirapine resistance after the use of single-dose
nevirapine to prevent mother-to-child HIV transmission, several research groups
are now experimenting with the use of drugs that can speed up the clearance of
nevirapine from the mother’s bloodstream after giving birth.
For
example, adding single dose-carbamazepine, a cheap, readily available
anti-convulsant
Categories: frontpage
Common side-effects of hepatitis C protease inhibitors: clinical management advice published
The addition of the protease inhibitors telaprevir or
boceprevir to hepatitis C treatment regimens increases the risk of anaemia,
according to a review article published in Liver
International. The author also found that telaprevir treatment was
associated with an increased risk of rash and itching as well as some anorectal
symptoms.
However, these side-effects were
Categories: frontpage